Biological Detection Systems

BioDetection Systems (BDS) is a specialized biotechnology company based in Amsterdam that provides advanced bio-based screening assays for the detection of chemical and biological activities. The company's core technology, CALUX (Chemically Activated LUciferase eXpression), utilizes a suite of genetically modified cell lines to identify and quantify the presence of substances such as dioxins, endocrine disruptors, and various pharmaceutical compounds. BDS serves the food, environmental, and pharmaceutical sectors by offering high-throughput screening services and assay kits that act as sensitive, cost-effective alternatives to animal testing. Their platform is integral to regulatory compliance and safety assessment, providing critical data on the toxicological profiles of complex mixtures and pure substances.